2015
Computed Tomography Angiography With High Flow Rates An In Vitro and In Vivo Feasibility Study
MIHL, Casper, Madeleine KOK, Joachim E. WILDBERGER, Jakub TUREK, Georg MUEHLENBRUCH et. al.Základní údaje
Originální název
Computed Tomography Angiography With High Flow Rates An In Vitro and In Vivo Feasibility Study
Autoři
MIHL, Casper (528 Nizozemské království), Madeleine KOK (528 Nizozemské království), Joachim E. WILDBERGER (528 Nizozemské království), Jakub TUREK (703 Slovensko, garant, domácí), Georg MUEHLENBRUCH (276 Německo) a Marco DAS (528 Nizozemské království)
Vydání
Investigative Radiology, Philadelphia, Lippincott Williams & Wilkins, 2015, 0020-9996
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30000 3. Medical and Health Sciences
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 4.887
Kód RIV
RIV/00216224:14110/15:00085178
Organizační jednotka
Lékařská fakulta
UT WoS
000356492400007
Klíčová slova anglicky
attenuation; cannula; computed tomography; contrast media; flow injection analysis; injection; phantom
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 20. 1. 2016 15:52, Ing. Mgr. Věra Pospíšilíková
Anotace
V originále
Objective The aims of this study were to test high-flow application of contrast media (CM) using novel high-flow needles and to assess injection- and flow-related parameters in a circulation phantom and in an in vivo population. Materials and Methods A circulation phantom simulating physiological parameters was used. Preheated CM (300 mg/mL) was injected at flow rates varying between 5 and 15 mL/s through a novel 18-gauge high-flow intravenous injection needle. In addition, feasibility of these high-flow needles was tested with administration of flow rates of 9 mL/s in 20 patients referred for pre-transcatheter aortic valve implantation assessment. Injection parameters (eg, peak pressures, peak flow rates) in both phantom and in vivo setup were continuously monitored by a data acquisition program. Attenuation at predefined levels of the aorta (eg, aortic root to common femoral arteries) was measured in all patients to determine clinical applicability. Results In the phantom setup, injection rates up to 15 mL/s were feasible. An enhancement plateau was reached at 11 mL/s (464 [20] HU). In patients, no pressure- or flow-related complications (eg, extravasation) were recorded (mean [SD] peak pressure, 154 [8] psi; mean [SD] peak flow rate, 9.2 [0.1 mL/s; range, 9.1-9.6]). Diagnostic attenuation values were reached at all predefined levels of the aorta (330.8 [113.1] HU to 622.9 [81.5] HU). Conclusions These results indicate that injections with 9 mL/s using high-flow injection needles are safe. The pressure limit of 325 psi was not reached, and the injections resulted in diagnostic attenuation values. Using this dedicated needle, high flow rates should not be considered a drawback for CM application in routine CT angiography examinations.